⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Pomerantz LLP Issues Reminder to Shareholders in Regeneron Pharmaceuticals, Inc. of Class Action – REGN
accessnewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Pomerantz LLP Informs Shareholders of Class Action Filing Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
REGN ALERT: Securities Fraud Class Action Launched Against Regeneron Pharmaceuticals, Inc. – September 14, 2026 Deadline
accessnewswire.com
REGN
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) Over Securities Violations – Contact Levi & Korsinsky Today
accessnewswire.com
REGN
REGN INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
REGN
September 14, 2026 Deadline: Join Class Action Lawsuit Against Regeneron Pharmaceuticals, Inc. (REGN) – Contact Levi & Korsinsky
accessnewswire.com
REGN
Pomerantz LLP Issues Reminder to Investors in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit – REGN
accessnewswire.com
REGN